Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News May 13 2025 | First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study Industry News In The News Industry Read More May 12 2025 | BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC Industry News In The News Industry Read More Apr 28 2025 | Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase Industry News In The News Industry Read More Apr 22 2025 | New Joint Scientific Statement on Ejection Fraction Released by Leading Heart Failure Organizations HFSA News In The News Journal of Cardiac Failure Press Release Research Statement Read More Apr 18 2025 | U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
May 13 2025 | First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study Industry News In The News Industry Read More
May 12 2025 | BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC Industry News In The News Industry Read More
Apr 28 2025 | Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase Industry News In The News Industry Read More
Apr 22 2025 | New Joint Scientific Statement on Ejection Fraction Released by Leading Heart Failure Organizations HFSA News In The News Journal of Cardiac Failure Press Release Research Statement Read More
Apr 18 2025 | U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications Industry News In The News Industry Read More
